Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Marco, Cavaleri"'
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-8 (2024)
Abstract Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory authorities worldwide. COVID-19 vaccines have been administered to se
Externí odkaz:
https://doaj.org/article/441fcc7f550349169b1d22b57ac5e1a2
Autor:
Alessandra Buoninfante, Arno Andeweg, Alexander T. Baker, Mitesh Borad, Nigel Crawford, Jean-Michel Dogné, David Garcia-Azorin, Andreas Greinacher, Rita Helfand, Anders Hviid, Stefan Kochanek, Marta López-Fauqued, Ishac Nazy, Anand Padmanabhan, Sue Pavord, Daniel Prieto-Alhambra, Huyen Tran, Ulla Wandel Liminga, Marco Cavaleri
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-6 (2022)
Safety and efficacy of vaccines against the SARS-CoV-2 coronavirus has been demonstrated in clinical trials and next by their real world use through the course of the ongoing COVID-19 pandemic. However, very rare adverse events have been detected pos
Externí odkaz:
https://doaj.org/article/65ba9e287bd445598845098cebb4daba
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-6 (2021)
Abstract Background Antimicrobial resistance (AMR) is a growing global problem to which the ongoing COVID-19 pandemic may further contribute. With resources deployed away from antimicrobial stewardship, evidence of substantial pre-emptive antibiotic
Externí odkaz:
https://doaj.org/article/709310eb95ba45b28990bb2748580b48
Autor:
Sieta T de Vries, Peter G M Mol, Harald Enzmann, Viktoriia Starokozhko, Ingrid M M Schellens, Leonoor Wijnans, Marco Cavaleri
Publikováno v:
BMJ Global Health, Vol 7, Iss 3 (2022)
An under-representation of women and a lack of sex-specific analyses in COVID-19 trials has been suggested. However, the higher number of men than women who are severely affected by COVID-19 and the restricted information in scientific publications m
Externí odkaz:
https://doaj.org/article/2a448a4269c14d4a8dd8d241447638df
Publikováno v:
PLoS Medicine, Vol 16, Iss 9, p e1002915 (2019)
Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.
Externí odkaz:
https://doaj.org/article/ab082010efd343748221e3584cb13c29
Autor:
Eric Pelfrene, Martin Harvey Allchurch, Nsengi Ntamabyaliro, Victoria Nambasa, Fátima V Ventura, Nithyanandan Nagercoil, Marco Cavaleri
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007381 (2019)
Externí odkaz:
https://doaj.org/article/4a409dedf06d4d26bf50406ef792ac3b
Autor:
Edwin J Asturias, Jean-Louis Excler, James Ackland, Marco Cavaleri, Alma Fulurija, Raj Long, Mignon McCulloch, Shiranee Sriskandan, Wellington Sun, Liesl Zühlke, Jerome H Kim, James B Dale, Andrew C Steer
Publikováno v:
Clinical Infectious Diseases.
Streptococcus. pyogenes (Strep A) infections result in a vastly underestimated burden of acute and chronic disease globally. The Strep A Vaccine Global Consortium (SAVAC) mission is to accelerate the development of safe, effective and affordable S. p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdbc6b6584f4b5d73d9471d23485309c
https://doi.org/10.1093/cid/ciad311
https://doi.org/10.1093/cid/ciad311
Publikováno v:
Vaccine Insights. 1:29-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4e9a9ff51adad3bd267dc03dded0df
https://doi.org/10.18609/vac.2022.006
https://doi.org/10.18609/vac.2022.006
Autor:
Sonali Kochhar, Draurio Barreira, Pauline Beattie, Marco Cavaleri, Alejandro Cravioto, Mike W. Frick, Ann M. Ginsberg, Ian Hudson, David C. Kaslow, Sherry Kurtz, Christian Lienhardt, Shabir A. Madhi, Christopher Morgan, Yalda Momeni, Deepali Patel, Helen Rees, Taryn Rogalski-Salter, Alexander Schmidt, Boitumelo Semete-Makokotlela, Gerald Voss, Richard G White, Matteo Zignol, Birgitte Giersing
Publikováno v:
Vaccine. 40:1681-1690
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7006703820bf7a4ca13542f7f87068e6
https://doi.org/10.1016/j.vaccine.2021.10.062
https://doi.org/10.1016/j.vaccine.2021.10.062
Autor:
William Ampofo, Michael T. Osterholm, Rebecca Jane Cox, Florian Krammer, Josephine P. Golding, Gagandeep Kang, Benjamin J. Cowling, Martin Friede, Ann Moen, Julia T. Ostrowsky, Cheryl Cohen, Joseph S. Bresee, Marilda M. Siqueira, Angela J. Mehr, Charlotte L. Weller, Kristine A. Moore, Bruce G. Gellin, Jerry P. Weir, Wendy S. Barclay, Alison Kraigsley, Ian D. Gust, Jacqueline M. Katz, Larisa Rudenko, Bruce L. Innis, Diane J. Post, Punnee Pitisuttithum, Peter Hart, Marco Cavaleri
Publikováno v:
Vaccine
Improved influenza vaccines are urgently needed to reduce the burden of seasonal influenza and to ensure a rapid and effective public-health response to future influenza pandemics. The Influenza Vaccines Research and Development (R&D) Roadmap (IVR) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a010c38475cdc8e876b9fc0552df07
https://doi.org/10.1016/j.vaccine.2021.08.010
https://doi.org/10.1016/j.vaccine.2021.08.010